WITHDRAWN: Incidence and mortality of COVID-19 in Iranian multiple sclerosis patients treated with disease-modifying therapies

M. Etemadifar, A. Aghababaee, N. Sedaghat, M. Rayani, H. Nouri, A. Abhari, M. Salari, N. Majdinasab, M. Ghiasian, A. Bayati, S.M. Nabavi, A. Mansouri

Open source

DOI
10.1016/j.neurol.2020.08.001
Published
2020-09
Container
Revue Neurologique
Publisher
Elsevier BV
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.neurol.2020.08.001,
  title = {WITHDRAWN: Incidence and mortality of COVID-19 in Iranian multiple sclerosis patients treated with disease-modifying therapies},
  author = {M. Etemadifar and A. Aghababaee and N. Sedaghat and M. Rayani and H. Nouri and A. Abhari and M. Salari and N. Majdinasab and M. Ghiasian and A. Bayati and S.M. Nabavi and A. Mansouri},
  year = {2020},
  journal = {Revue Neurologique},
  doi = {10.1016/j.neurol.2020.08.001},
  url = {https://doi.org/10.1016/j.neurol.2020.08.001}
}

RIS

TY  - JOUR
TI  - WITHDRAWN: Incidence and mortality of COVID-19 in Iranian multiple sclerosis patients treated with disease-modifying therapies
AU  - M. Etemadifar
AU  - A. Aghababaee
AU  - N. Sedaghat
AU  - M. Rayani
AU  - H. Nouri
AU  - A. Abhari
AU  - M. Salari
AU  - N. Majdinasab
AU  - M. Ghiasian
AU  - A. Bayati
AU  - S.M. Nabavi
AU  - A. Mansouri
PY  - 2020
JO  - Revue Neurologique
DO  - 10.1016/j.neurol.2020.08.001
UR  - https://doi.org/10.1016/j.neurol.2020.08.001
ER  - 

APA

Etemadifar, M., Aghababaee, A., Sedaghat, N., Rayani, M., Nouri, H., Abhari, A., Salari, M., Majdinasab, N., Ghiasian, M., Bayati, A., Nabavi, S., & Mansouri, A. (2020). WITHDRAWN: Incidence and mortality of COVID-19 in Iranian multiple sclerosis patients treated with disease-modifying therapies. Revue Neurologique. https://doi.org/10.1016/j.neurol.2020.08.001

Source records